These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26721295)

  • 21. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.
    Hoffmann K; Kerner C; Wilfert W; Mueller M; Thiery J; Hauss J; Witzigmann H
    World J Gastroenterol; 2007 Jan; 13(2):257-63. PubMed ID: 17226905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
    Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK
    Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
    Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer stem cells: features and detection methods.
    Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
    Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma.
    Muroni M; D'Angelo F; Pezzatini M; Sebastiani S; Noto S; Pilozzi E; Ramacciato G
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):97-9. PubMed ID: 20133238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma.
    Tanaka M
    Pancreas; 2018; 47(5):544-550. PubMed ID: 29702531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making?
    Ansari D; Aronsson L; Andersson R
    Future Oncol; 2017 Aug; 13(20):1751-1753. PubMed ID: 28831817
    [No Abstract]   [Full Text] [Related]  

  • 30. Pancreatic cancer: current understanding of molecular and genetic aetiologies.
    Gall TM; Wasan H; Jiao LR
    Postgrad Med J; 2015 Oct; 91(1080):594-600. PubMed ID: 26124188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers in pancreatic ductal adenocarcinoma.
    Gallego J; López C; Pazo-Cid R; López-Ríos F; Carrato A
    Clin Transl Oncol; 2017 Dec; 19(12):1430-1437. PubMed ID: 28616721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for Pancreatic Cancer: Recommendation Statement.
    Am Fam Physician; 2019 Dec; 100(12):Online. PubMed ID: 31845783
    [No Abstract]   [Full Text] [Related]  

  • 33. Intercepting Cancer Communiques: Exosomes as Heralds of Malignancy.
    Hingorani SR
    Cancer Cell; 2015 Aug; 28(2):151-3. PubMed ID: 26267532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early detection of sporadic pancreatic cancer: summative review.
    Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
    Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
    Kenner BJ; Chari ST; Cleeter DF; Go VL
    Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-metabolite panel for early-stage pancreatic cancer.
    Burki TK
    Lancet Oncol; 2018 Oct; 19(10):e512. PubMed ID: 30146244
    [No Abstract]   [Full Text] [Related]  

  • 37. Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: a histochemical, immunohistochemical, and molecular report.
    Bellevicine C; Malapelle U; Iaccarino A; Schettino P; Napolitano V; Zeppa P; Troncone G
    Diagn Cytopathol; 2013 Jan; 41(1):77-80. PubMed ID: 23008087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.
    Kim J; Bamlet WR; Oberg AL; Chaffee KG; Donahue G; Cao XJ; Chari S; Garcia BA; Petersen GM; Zaret KS
    Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mixed ductal endocrine carcinoma of the pancreas].
    Zehani A; Chelly I; Azouz H; Makni A; Haouet S; Kchir N
    Ann Pathol; 2012 Aug; 32(4):296-8. PubMed ID: 23010408
    [No Abstract]   [Full Text] [Related]  

  • 40. Early detection of pancreatic cancer.
    Pereira SP; Oldfield L; Ney A; Hart PA; Keane MG; Pandol SJ; Li D; Greenhalf W; Jeon CY; Koay EJ; Almario CV; Halloran C; Lennon AM; Costello E
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):698-710. PubMed ID: 32135127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.